2BB score and signals
Immunovant, Inc.’s current 2BB score is 11 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 3 | Very Low |
| Momentum | 34 | Weakening |
| Financial strength | 21 | Weak |
| Quality | 100 | Very Strong |
| Risk | 36 | Low |
Immunovant, Inc. (IMVT) Stock Score & Signals
Immunovant, Inc. (IMVT) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 11 out of 100.
Company facts
| Founded | 2018 |
| Employees | 315 |
| 52-week range | $14.47 – $45.35 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-04 | — | -0.7491 | — | $0.00 |
| 2026-11-09 | — | -0.7227 | — | $0.00 |
| 2026-08-06 | — | -0.6277 | — | $0.00 |
| 2026-05-20 | -0.73 | -0.6129 | $0.00 | $0.00 |